Brief: Roche Develops PCR Test For Ebola Bundibugyo Virus
04/06/2026 16:45
BRIEF-Roche Develops PCR Test For Ebola Bundibugyo Virus June 4 (Reuters) - Roche Holding AG ROPC.S:
ROCHE RAPIDLY DEVELOPS A PCR TEST FOR EBOLA WITHIN SIX DAYS AS RARE BUNDIBUGYO VIRUS DRIVES URGENT NEED FOR DETECTION
ROCHE HOLDING AG - WORKING WITH PUBLIC HEALTH LABS TO PROVIDE PCR TESTING FOR EBOLA OUTBREAK
Source text: ID:nPn88jLC6a
Further company coverage: ROPC.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Roche Holding AG
See all newsTable: Swiss trade surplus at CHF 6.11 bln in May
Brief: Roche - FDA Accepts Supplemental Biologics License Application For Lunsumio And Polivy Combination
Swiss stocks - Factors to watch on June 18
FDA approves first generic version of Roche's flu drug
Brief: FDA Approves First Single-Dose Generic Treatment For Influenza